CIK 0001756594 · Pharmaceutical Preparations (SIC 2834) · Nasdaq, OTC · incorporated in I0 · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-06 | 6-K | FORM 6-K | 2026-10-06 |
| 2026-09-28 | 6-K | FORM 6-K | 2026-06-30 |
| 2026-09-03 | 6-K | FORM 6-K | 2026-09-02 |
| 2026-09-01 | 6-K | FORM 6-K | 2026-08-31 |
| 2026-07-30 | 6-K/A | FORM 6-K/A | 2026-07-30 |
| 2026-07-29 | 6-K | FORM 6-K | 2026-07-29 |
| 2026-07-09 | 6-K | FORM 6-K | 2026-07-09 |
| 2026-07-06 | 6-K | FORM 6-K | 2026-07-02 |
| 2026-06-12 | 6-K | FORM 6-K | 2026-06-12 |
| 2026-06-12 | 6-K | FORM 6-K | 2026-06-12 |
| 2026-06-09 | 6-K | FORM 6-K | 2026-06-09 |
| 2026-06-03 | 6-K | FORM 6-K | 2026-06-03 |
| 2026-06-03 | 6-K | FORM 6-K | 2026-06-02 |
| 2026-06-02 | 424B5 | 424B5 | |
| 2026-06-02 | FWP | FWP | |
| 2026-06-02 | F-3ASR | F-3ASR | |
| 2026-05-26 | 6-K | FORM 6-K | 2026-05-26 |
| 2026-05-22 | 6-K | FORM 6-K | 2026-05-22 |
| 2026-05-15 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-04-22 | 6-K | FORM 6-K | 2026-04-22 |
| 2026-04-08 | 20-F | 20-F | 2025-12-31 |
| 2026-04-01 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-03-30 | 6-K | FORM 6-K | 2026-03-30 |
| 2026-02-17 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-02-17 | SCHEDULE 13G/A | SCHEDULE 13G/A |
Forms on file (last 1,000): 6-K 145, SCHEDULE 13G/A 13, 20-F 6, SCHEDULE 13D/A 6, SCHEDULE 13G 6, SC 13D/A 5, SC 13G 5, 424B5 4. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=IVA (0.002 USD), /gw/filings/filings?ticker=IVA&form=8-K, /gw/filings/facts?ticker=IVA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange